View Older Stories
-
Q1 MedTech quarterly preview: BTIG
-
Bernstein SocGen Group Reiterates Outperform Rating on Alcon Inc. (ALC), 'more bullish on the opportunity'
-
Alcon terminates LENSAR merger agreement after FTC opposition
-
This MedTech stock is a new best idea at Bernstein
-
UBS Reiterates Buy and Top Large Cap Pick Rating on Alcon Inc. (ALC:SW) (ALC)
-
UBS Reiterates Buy and Top Large Cap Pick Rating on Alcon Inc. (ALC:SW) (ALC)
-
Alcon Inc. (ALC) PT Raised to $82 at Stifel: 'Stock More Ownable Near-Term'
-
Bernstein SocGen Group Reiterates Outperform Rating on Alcon Inc. (ALC:SW) (ALC), Moves to Top Pick
-
Wells Fargo Upgrades Alcon Inc. (ALC) to Overweight
-
Alcon Inc. (ALC:SW) (ALC) PT Raised to CHF81.50 at Bernstein SocGen Group
-
Alcon Inc. (ALC) PT Raised to $100 at Needham
-
Alcon (ALC) Reports In-Line Q4 EPS
-
Alcon launches PRECISION7 weekly contact lens in Canada
-
William Blair Starts Alcon Inc. (ALC) at Market Perform
-
KeyBanc on Medical Technology: 'From Reset to Rebound?'
-
Deutsche Bank Upgrades Alcon Inc. (ALC:SW) (ALC) to Buy
-
Alcon (ALC) Reiterated at Hold by Stifel: UNITY VCS/CS Survey Mixed
-
Bernstein on EU Medtech: 'A Buying Opportunity or Is It Simply a Value Trap?'
-
Stifel Downgrades Alcon Inc. (ALC) to Hold
-
Broadwood Partners Comments on STAAR Surgical Shareholders’ Rejection of Proposed Sale to Alcon
-
Broadwood criticizes STAAR Surgical's fourth delay of shareholder vote
-
Alcon exercises right to adjourn STAAR Surgical stockholder meeting
-
Defender Capital opposes STAAR Surgical sale to Alcon ahead of vote
-
Broadwood pledges cooperation with STAAR Surgical after Alcon deal vote
-
STAAR Surgical urges shareholders to approve Alcon's $30.75 per share offer
-
ISS recommends STAAR Surgical deal, but warns shareholders have reason to object
-
Yunqi Capital opposes STAAR merger with Alcon despite revised offer
-
STAAR Surgical gets analyst support for Alcon merger at $30.75 per share
-
Broadwood Partners opposes STAAR Surgical sale to Alcon amid proxy concerns
-
Glass Lewis reaffirms opposition to STAAR Surgical sale to Alcon
-
STAAR Surgical defends merger process amid activist criticism
-
Broadwood opposes revised STAAR Surgical-Alcon deal, cites board dissent
-
BofA Securities Double Downgrades Alcon Inc. (ALC) to Underperform
-
BofA Securities Double Downgrades Alcon Inc. (ALC:SW) (ALC) to Underperform
-
Yunqi Capital opposes STAAR Surgical merger despite Alcon's raised bid
-
Alcon bumps STAAR Surgical bid to $30.75, but Broadwood remains vehemently against
-
Broadwood opposes revised STAAR Surgical acquisition by Alcon
-
Alcon raises STAAR acquisition price to $30.75 per share
-
Broadwood Partners maintains opposition to STAAR Surgical sale to Alcon
-
Egan-Jones reaffirms vote against STAAR Surgical sale to Alcon
-
STAAR Surgical's go-shop period expires with no competing bids
-
Broadwood reiterates push for STAAR Surgical board shake-up as Alcon vote nears
-
Broadwood Partners seeks to remove three STAAR Surgical directors
-
STAAR Surgical reveals board dissent over amended Alcon deal ahead of vote
-
Alcon Inc. (ALC) PT Lowered to $101.09 at Bernstein
-
Exclusive: Broadwood says Alcon's earnings reveal STAAR bid came from 'weakness'
-
Needham Reiterates Buy Rating on Alcon Inc. (ALC)
-
Broadwood calls for new directors at STAAR Surgical for go-shop oversight
-
STAAR Surgical amends Alcon merger deal to allow 30-day bidding period
-
Increasing unusual put option volume: NTR MTSR HUBS BKSY FSLY SLDP ELF FSK DASH DB EH RDW FLR ALC

